Abbott Laboratories ABTT34 Balance Sheet

Income Statement

Quarter End	Jun 2022	Sep 2022	Dec 2022	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024
	USD ($)	USD ($)	USD ($)	USD ($)	USD ($)	USD ($)	USD ($)	USD ($)
Total Assets	74.2B	72.8B	74.44B	73.79B	73.35B	72.09B	73.21B	72.47B
Total Current Assets	24.96B	24.85B	25.22B	24.38B	23.51B	22.66B	22.67B	22.38B
Cash and Equivalents	8.94B	9.59B	9.88B	9.16B	7.84B	6.71B	6.9B	6.28B
Total Non-Current Assets	58.06B	56.65B	58.38B	58.7B	59.3B	58.98B	60.7B	60.2B
Total Liabilities	37.49B	36.92B	37.53B	36.56B	35.95B	34.4B	34.39B	33.42B
Total Current Liabilities	12.39B	13.37B	15.49B	14.53B	14.35B	13.04B	13.84B	14.02B
Total Non-Current Liabilities	41.41B	38.44B	36.57B	36.65B	36.16B	35.43B	34.15B	31.98B
Common Equity	24.43B	24.56B	24.71B	24.49B	24.61B	24.73B	24.87B	24.73B
Retained Earnings	34.49B	35.12B	35.26B	35.87B	36.36B	36.92B	37.55B	38.01B

Year End December 30 2023	2016	2017	2018	2019	2020	2021	2022	2023
	USD ($)	USD ($)	USD ($)	USD ($)	USD ($)	USD ($)	USD ($)	USD ($)
Total Assets	52.67B	76.25B	67.17B	67.89B	72.55B	75.2B	74.44B	73.21B
Total Current Assets	26.78B	20.15B	14.63B	15.67B	20.44B	24.24B	25.22B	22.67B
Cash and Equivalents	18.62B	9.41B	3.84B	3.86B	6.84B	9.8B	9.88B	6.9B
Total Non-Current Assets	20.72B	31.1B	30.72B	31.3B	33B	36.02B	36.91B	38.83B
Total Liabilities	31.95B	45.15B	36.45B	36.59B	39.55B	39.17B	37.53B	34.39B
Total Current Liabilities	6.66B	8.91B	9.01B	10.86B	11.91B	13.11B	15.49B	13.84B
Total Non-Current Liabilities	45.97B	63.45B	46.8B	42.38B	46.17B	42.84B	36.57B	34.15B
Total Equity	20.72B	31.1B	30.72B	31.3B	33B	36.02B	36.91B	38.83B
Common Equity	13.03B	23.21B	23.51B	23.85B	24.15B	24.47B	24.71B	24.87B
Retained Earnings	25.57B	23.98B	24.56B	25.85B	27.63B	31.53B	35.26B	37.55B